LRRK2 and Parkinson disease: Moreover, mounting evidence supports that because of its multiple enzymatic and protein-binding domains, LRRK2 regulates varied pathways other than PD including the autophagy process by mTOR signaling [6], microglia activation, and CD4 and CD8 cell infiltration in cancer and inflammatory bowel disease (IBS) [7,8,9].